KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Inventory Average (2016 - 2025)

Pfizer (PFE) has disclosed Inventory Average for 16 consecutive years, with $11.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average fell 1.99% to $11.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $11.1 billion, a 1.99% decrease, with the full-year FY2025 number at $10.8 billion, up 2.21% from a year prior.
  • Inventory Average was $11.1 billion for Q4 2025 at Pfizer, down from $11.6 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $11.6 billion in Q3 2024 to a low of $8.3 billion in Q2 2021.
  • A 5-year average of $10.1 billion and a median of $10.2 billion in 2022 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: increased 17.15% in 2022, then fell 2.85% in 2023.
  • Pfizer's Inventory Average stood at $8.8 billion in 2021, then grew by 4.49% to $9.2 billion in 2022, then rose by 10.27% to $10.2 billion in 2023, then rose by 10.69% to $11.3 billion in 2024, then fell by 1.99% to $11.1 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Inventory Average are $11.1 billion (Q4 2025), $11.6 billion (Q3 2025), and $11.3 billion (Q2 2025).